Obesity-Induced Cellular Senescence Drives Anxiety and Impairs Neurogenesis
Mikołaj Ogrodnik(Austrian Cluster for Tissue Regeneration), Diana Jurk(Mayo Clinic in Florida), Nino Giorgadze(Mayo Clinic in Florida), James L. Kirkland(Cedars-Sinai Medical Center), Christine Inman(Mayo Clinic), Ming Xu(Mayo Clinic in Florida), Grigori Enikolopov(Stony Brook University), Tamar Tchkonia(Cedars-Sinai Medical Center), Edward Fielder(Newcastle University), Allyson K. Palmer(Mayo Clinic), Stella Victorelli(Mayo Clinic in Florida), Tamar Pirtskhalava(Mayo Clinic in Florida), Rifqha A. Ruswhandi(Newcastle Hospitals - Campus for Ageing and Vitality), Kurt O. Johnson(Mayo Clinic), Oleg Podgorni(Stony Brook School), Thomas von Zglinicki(Newcastle University), Moritz Weigl(Motlow State Community College), Yuji Ikeno(The University of Texas at San Antonio Health Science Center), Patrick Krüger(Newcastle Hospitals - Campus for Ageing and Vitality), Yi Zhu(University of Macau), Terry C. Burns(Neurological Surgery), Marissa Schafer(WinnMed), João F. Passos(Newcastle University)
Cited by 547
Related Papers
The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs
|Aging Cell|2015|2.4k
Cellular senescence mediates fibrotic pulmonary disease
|Nature Communications|2017|1.5k
Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
|EBioMedicine|2019|1.3k
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
|EBioMedicine|2019|1.2k
Cellular senescence drives age-dependent hepatic steatosis
|Nature Communications|2017|1k